ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,109.25
0.15%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Viatris Inc (VTRS)

  7. Viatris Inc (VTRS) News

Viatris (VTRS)

Viatris Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VTRS
DateTimeSourceHeadlineSymbolCompany
07/06/202411:59PR Newswire (US)Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024NASDAQ:VTRSViatris Inc
04/06/202411:59PR Newswire (US)Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:VTRSViatris Inc
03/06/202412:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTRSViatris Inc
03/06/202411:59PR Newswire (US)Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of DirectorsNASDAQ:VTRSViatris Inc
31/05/202411:59PR Newswire (US)Viatris to Participate in the Jeffries Global Healthcare ConferenceNASDAQ:VTRSViatris Inc
28/05/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
28/05/202421:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTRSViatris Inc
21/05/202411:59PR Newswire (US)Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at ScaleNASDAQ:VTRSViatris Inc
09/05/202412:47IH Market NewsU.S. Index Futures Dip, Bank of England Holds Interest Rates at 5.25%NASDAQ:VTRSViatris Inc
09/05/202412:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTRSViatris Inc
09/05/202411:59PR Newswire (US)Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance RangesNASDAQ:VTRSViatris Inc
02/05/202422:00PR Newswire (US)Viatris to Participate in the BofA Securities 2024 Health Care ConferenceNASDAQ:VTRSViatris Inc
01/05/202411:59PR Newswire (US)Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental HealthNASDAQ:VTRSViatris Inc
16/04/202421:30PR Newswire (US)Viatris to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:VTRSViatris Inc
15/04/202413:00PR Newswire (US)Viatris Appoints Corinne Le Goff as Chief Commercial OfficerNASDAQ:VTRSViatris Inc
15/04/202411:59PR Newswire (Canada)Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in CanadaNASDAQ:VTRSViatris Inc
15/04/202411:59PR Newswire (Canada)Viatris annonce le lancement de la première version générique bioéquivalente du Copaxone [MD] 20 mg/mL au CanadaNASDAQ:VTRSViatris Inc
01/04/202411:59PR Newswire (US)Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United StatesNASDAQ:VTRSViatris Inc
27/03/202410:59PR Newswire (US)Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its PipelineNASDAQ:VTRSViatris Inc
06/03/202401:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
06/03/202401:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
06/03/202401:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
06/03/202400:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
06/03/202400:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
06/03/202400:26Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
04/03/202423:11Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTRSViatris Inc
28/02/202412:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTRSViatris Inc
28/02/202411:30PR Newswire (US)Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial GuidanceNASDAQ:VTRSViatris Inc
28/02/202406:00PR Newswire (US)Viatris and Idorsia Enter Into Significant Global Research and Development CollaborationNASDAQ:VTRSViatris Inc
23/02/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
 Showing the most relevant articles for your search:NASDAQ:VTRS

Your Recent History

NASDAQ
AAYZSXX
Citigroup Global Markets...
LSE
54PB
Bp Cap.27
COIN
VOLLAREUR
V-Dimension
NASDAQ
VVMAX
Securian AM Balanced Sta...
BMF
VF3F25P001150
VF3F25P001150 - 01/2025
TG
A285YE
Stora Enso Oyj
BIT
P04639
Bnp Paribas Issuance
TG
A3G9AF
Virtune Bitcoin
COIN
ETHBEARUSD
NASDAQ
CSF
VictoryShares US Discove...
NASDAQ
EXAC
COIN
MRCOBTC
BIT
I08685
Intesa Sanpaolo
BOV
SHOW3
TIME FOR FUN ON
LSE
1MCS
Wt Ftse250 1x S
UPBT
BLOCKBTC
Blocknet
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved